Bristol-Myers Squibb (BMY) Short Interest Ratio & Short Volume

Short interest is the volume of Bristol-Myers Squibb shares that have been sold short but have not yet been covered or closed out. As of September 15th, investors have sold 36,980,000 shares of BMY short. 1.77% of Bristol-Myers Squibb's shares are currently sold short. Learn More on Bristol-Myers Squibb's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BMY shares currently have a short interest ratio of 4.0. Learn More on Bristol-Myers Squibb's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bristol-Myers Squibb: Wolverine Trading LLC, Wells Fargo & Company MN, Walleye Capital LLC, Walleye Trading LLC, Worth Venture Partners LLC, Goldman Sachs Group Inc., Point72 Asset Management L.P., Point72 Middle East FZE, Boothbay Fund Management LLC, Citadel Advisors LLC, CMT Capital Markets Trading GmbH, Capula Management Ltd, Tudor Investment Corp Et Al, Two Sigma Securities LLC, Eisler Capital US LLC, Marshall Wace LLP, Garda Capital Partners LP, Caption Management LLC, Capital Fund Management S.A., Parallax Volatility Advisers L.P., Alphadyne Asset Management LP, PEAK6 Investments LLC, Hsbc Holdings PLC, HAP Trading LLC, JPMorgan Chase & Co., Citigroup Inc., BNP Paribas Arbitrage SNC, Lido Advisors LLC, XR Securities LLC, Wolverine Asset Management LLC, Simplex Trading LLC, Maven Securities LTD, Barclays PLC, LPL Financial LLC, SpiderRock Advisors LLC, Cutler Group LLC CA, IMC Chicago LLC, and Washington Capital Management Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.77% of Bristol-Myers Squibb's floating shares are currently sold short.

Bristol-Myers Squibb saw a drop in short interest during the month of September. As of September 15th, there was short interest totaling 36,980,000 shares, a drop of 15.5% from the previous total of 43,760,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Bristol-Myers Squibb currently has issued a total of 2,089,103,000 shares. Some of Bristol-Myers Squibb's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bristol-Myers Squibb currently has a public float of 2,090,000,000 shares.

1.77% of Bristol-Myers Squibb's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Bristol-Myers Squibb: Zoetis Inc. (0.76%), Pfizer Inc. (0.88%), Merck & Co., Inc. (0.55%), AbbVie Inc. (0.68%), Johnson & Johnson (0.93%), Sanofi (0.15%), Vertex Pharmaceuticals Incorporated (1.11%), Regeneron Pharmaceuticals, Inc. (1.40%), Abbott Laboratories (0.62%), GSK plc (0.27%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($8.05 billion), T-Mobile US, Inc. ($3.94 billion), Charter Communications, Inc. ($3.77 billion), Occidental Petroleum Co. ($3.27 billion), Tractor Supply ($2.29 billion), Celsius Holdings, Inc. ($2.20 billion), Rivian Automotive, Inc. ($2.10 billion), Moderna, Inc. ($2.08 billion), Royal Caribbean Cruises Ltd. ($1.90 billion), and T. Rowe Price Group, Inc. ($1.90 billion). View all of the most shorted stocks.

Short selling BMY is an investing strategy that aims to generate trading profit from Bristol-Myers Squibb as its price is falling. BMY shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Bristol-Myers Squibb occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BMY, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BMY, twice per month. The most recent reporting period available is September, 15 2023.